Public reactions to facial psoriasis, atopic dermatitis, vitiligo, and alopecia areata

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study measures differences in emotional reactions and social stigma toward four dermatologic conditions when they affect the face by showing participants AI-generated facial images representing each condition. Participants will indicate which images evoke compassion/pity, disgust, blame/disapproval/disdain, and curiosity, and will complete a 14-question Likert stigma questionnaire focused on one randomly selected disease. Basic demographic data (age, gender, employment, education) will be collected and total stigma scores will range from 14 to 70, with lower scores indicating greater stigma. People with personal or first-degree family diagnoses of these conditions or with direct professional/personal knowledge are excluded, and the study is conducted at the dermatology unit of Fondazione Policlinico Universitario A. Gemelli in Rome.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* -Patients aged\>18 years, both sexes;
* Signature of written informed consent;

Exclusion Criteria:

* Patients diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata.
* Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo or alopecia areata
* Those who for professional or personal reasons have direct knowledge of the diseases in question.

Where it's running

• Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia
  Roma, Italia, Italy Recruiting

Study contacts

• Principal investigator: Giacomo Caldarola, MD — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• Study coordinator: Caldarola
• Email: giacomo.caldarola@unicatt.it
• Phone: +390630155284

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PALLAS 311 nm UVB laser treatment for vitiligo, psoriasis, alopecia areata, and atopic dermatitis

  This study will test the PALLAS 311 nm UVB laser as an in-clinic, twice-weekly treatment for adults with vitiligo, psoriasis, alopecia areata, or atopic dermatitis for up to three months.

  Recruiting Szeged University · Szeged, Csongrád-Csanád Vármegye · NCT07250997

• Roflumilast Cream 0.3% for moderate to severe atopic dermatitis in children, adolescents, and adults

  A cream called roflumilast 0.3% is tested once daily to see if it helps people with moderate to severe atopic dermatitis, compared to a non-medicated cream, across ages 6 and up.

  Recruiting at 4 sites Phase 3 Arcutis Biotherapeutics, Inc. · Birmingham, Alabama and 3 other locations · NCT07916480

• Nocturnal ScratchSense ring: test of automatic scratch detection in adults with itchy skin

  This study tests whether the Replior ScratchSense ring can accurately detect and measure nighttime scratching in adults with itchy skin conditions.

  Recruiting Replior AB · Grenoble · NCT07909967

• ADBest TREAT Registry for adults with atopic dermatitis

  A registry in Germany is collecting real-world data from adults with atopic dermatitis to see how treatments are used and how the disease affects quality of life.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg · NCT07904546

• Retinal Vessel Density and Foveal Avascular Zone Size in Psoriatic Arthritis

  This study tests whether retinal blood vessel density and the size of the foveal avascular zone differ between people with psoriatic arthritis, people with psoriasis, and healthy individuals using non-invasive eye imaging.

  Recruiting Bursa Yuksek Ihtisas Training and Research Hospital · Bursa, Yıldırım · NCT07858591

• How lebrikizumab affects the skin microbiome and mycobiome in adults with atopic dermatitis

  This study looks at whether lebrikizumab changes the skin bacteria, fungi, and specifically Staphylococcus species, in adults with moderate-to-severe atopic dermatitis.

  Recruiting University Hospital Bispebjerg and Frederiksberg · Copenhagen · NCT07807228

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.